Brief: Repare Therapeutics Provides Business Update And Reports First Quarter 2023 Financial Results

Repare Therapeutics

09/05/2023 22:40

Repare Therapeutics Inc  RPTX.O :
    * REPARE THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * ON TRACK TO REPORT INITIAL RP-6306 MONOTHERAPY DATA FROM
PHASE 1
MYTHIC CLINICAL TRIAL IN JUNE 2023
    * NET LOSS WAS $34.9 MILLION, OR $0.83 PER SHARE, IN THE
THREE
MONTHS ENDED MARCH 31, 2023
    * Q1 EARNINGS PER SHARE VIEW $-0.81 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5ZpbHca 
Further company coverage:  RPTX.O